Table. 1.

Table. 1.

Clinicopathologic characteristics of subjects

Variable Control group (27 cases) Experimental group (22 cases) p-value
Sex (male : female) 15 (55.6) : 12 (44.4) 16 (72.7) : 6 (27.3) 0.248
Age (yr) 61.5 ± 13.43 67.0 ± 10.09 0.120
Major diagnosis 0.813
HCC 14 (51.9) 11 (50.0)
CCLM 4 (14.8) 6 (27.3)
CCC 3 (11.1) 2 (9.1)
Pancreatic cancer 3 (11.1) 2 (9.1)
Benign liver disease 2 (7.4) 0 (0)
Benign pancreas disease 1 (3.7) 1 (4.5)
Operation (Open : Lapa) 11 (40.7) : 16 (59.3) 10 (45.5) : 12 (54.5) 0.740
Operation (liver : pancreas) 23 (85.2) : 4 (14.8) 19 (86.4) : 3 (13.6) 1.000
Laboratory data
Preop. albumin (g/dL) 4.0 ± 0.4 4.1 ± 0.4 0.376
Postop. albumin (g/dL) 3.2 ± 0.5 3.1 ± 0.3 0.772
Preop. cholesterol (mg/dL) 162.7 ± 41.9 155.3 ± 41.1 0.538
Postop. cholesterol (mg/dL) 112.7 ± 25.6 111.9 ± 30.4 0.922
Postop. pre-albumin (mg/L) 93.4 ± 26.1 90.6 ± 28.6 0.720

Values are presented as number (%) or mean ± standard deviation.

HCC, hepatocellular carcinoma; CCLM, colon cancer liver metastasis; CCC, cholangiocellular carcinoma; Open, conventional open operation; Lapa, laparoscopic operations; Preop., preoperative; Postop., postoperative.

Ann Hepatobiliary Pancreat Surg 2022;26:244-50 https://doi.org/10.14701/ahbps.21-152
© 2022 Ann Hepatobiliary Pancreat Surg